您的位置: 首页 > 农业专利 > 详情页

compound, pharmaceutical composition, kit, methods for inhibiting a jak kinase activity, for treating a disease, for treating allograft transplant rejection in a transplant recipient, for treating a hypersensitivity reaction, and for inhibiting a transduction cascade signal and compound use
专利权人:
RIGEL PHARMACEUTICALS; INC.
发明人:
DARREN JOHN MCMURTRIE,HUI LI,PINGYU DING,RAJINDER SINGH,ROSE YEN,SAMBAIAH THOTA,THILO J. HECKRODT,VANESSA TAYLOR,YAN CHEN
申请号:
BRPI1006942
公开号:
BRPI1006942A2
申请日:
2010.01.22
申请国别(地区):
BR
年份:
2016
代理人:
摘要:
Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK 2 and JAK3, are therapeutically useful.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充